Search
Genenta Science SPA
GNTAAdd to Watchlist
0.628USD
-0.002-0.32%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
14.82MMarket Cap
LossP/E TTM
More Details of Genenta Science SPA Company
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Info
Ticker SymbolGNTA
Company nameGenenta Science SPA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Number of employees13
Security typeDepository Receipt
Fiscal year-endDec 15
AddressVia Olgettina 58
CityMILANO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryItaly
Postal code20132
Phone
Websitehttps://www.genenta.com/
Ticker SymbolGNTA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Company Executives of Genenta Science SPA
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
+0.28%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+9.93%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
+0.28%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+9.93%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 7
Updated: Thu, May 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
9.76%
IRCCS Ospedale San Raffaele
8.04%
Naldini (Luigi M.D., Ph.D.)
5.88%
Roveda (Gaudenzio)
4.14%
Fidim S.r.l.
3.81%
Other
68.37%
Shareholders
Shareholders
Proportion
Paracchi (Pierluigi)
9.76%
IRCCS Ospedale San Raffaele
8.04%
Naldini (Luigi M.D., Ph.D.)
5.88%
Roveda (Gaudenzio)
4.14%
Fidim S.r.l.
3.81%
Other
68.37%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.70%
Corporation
16.04%
Hedge Fund
6.87%
Investment Advisor
5.10%
Holding Company
2.86%
Investment Advisor/Hedge Fund
1.02%
Sovereign Wealth Fund
0.96%
Research Firm
0.19%
Bank and Trust
0.01%
Other
41.25%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
24
3.34M
14.15%
+1.02M
2025Q4
19
1.83M
9.54%
-414.06K
2025Q3
16
1.96M
10.22%
-334.32K
2025Q2
24
9.06M
49.52%
-260.05K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Paracchi (Pierluigi)
2.30M
9.83%
+6.39K
+0.28%
Jan 25, 2026
IRCCS Ospedale San Raffaele
1.90M
8.09%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
5.92%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
2.96%
--
--
Mar 26, 2025
Citadel Advisors LLC
655.16K
2.8%
+642.68K
+5147.19%
Dec 31, 2025
Russo (Carlo)
602.42K
2.57%
+4.00K
+0.67%
Mar 26, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
